NightWatch
Take control of epilepsy at night
Effective seizure detection system
Caring for people with epilepsy is demanding and often stressful.
Seizures can be frightening. Some may cause serious injury or lead to Sudden Unexpected Death in Epilepsy (SUDEP), particularly when seizures occur at night without supervision.
NightWatch+ detects the most dangerous seizures during sleep and alerts caregivers. Its clinically proven performance improves nighttime safety and reduces caregiver stress.
Try for 30 days
Order NightWatch+ now and test it for 30 days.
NightWatch+
NightWatch+ consists of a comfortable, wireless sensor worn on the upper arm that continuously monitors heart rate and movement during sleep to detect seizures.
The US version of NightWatch+ is intended for use at home or in residential care settings by children aged 4 to 16 years who are diagnosed with epilepsy and experience nocturnal epileptic motor seizures, as well as by their caregivers. When a potentially dangerous seizure is detected, the sensor wirelessly transmits an alert to the alarm station, notifying a caregiver.
NightWatch+ seizure detection technology was invented and developed in collaboration with neurologists, patient organizations, universities, and high-tech industry partners.
| Audio and visual alarms when a possible epileptic seizure is detected | |
| Ready to use out of the box, with no configuration required | |
| Free access to the NightWatch portal for seizure monitoring | |
| Alarm notifications can be forwarded to nurse call systems (PRO version only) | |
| Designed for maintenance-free everyday use |
Nocturnal epileptic seizures
NightWatch+ detects the following seizure types:
- Tonic-Clonic seizures (TC)
-
Tonic seizures (if clustered or prolonged >30 seconds)
-
Hyperkinetic seizures
-
TC-like seizures
The NightWatch Portal
NightWatch+ can upload detailed sensor data to an online portal, if connected to the internet. This helps caregivers understand how the night progressed and why alarms may have been generated. Setup instructions are included in the portal manual.
Clinical validation of NightWatch
NightWatch has undergone rigorous clinical validation in the home setting. During its study, 2310 nights (28173 h), including 552 nocturnal epileptic major motor seizures, were analyzed for children (4-16 years of age). For children, the mean sensitivity for all major motor seizure types NightWatch detects is 90%, and for tonic-clonic seizures, the most dangerous seizure type, it is 98%.
The detection algorithm technology was validated over thousands of nights by the Dutch Epilepsy Center SEIN and the Academic Center for Epileptology at Kempenhaeghe. Their findings showed the technology to be significantly more effective than alternative approaches.
Built with Certified Quality and FDA Clearance
 |
The US version of NightWatch+ is a medical device cleared by the U.S. Food and Drug Administration (FDA) under 510(k) number K243199. It is manufactured in the USA under a Quality Management System certified to ISO 13485 and compliant with 21 CFR Part 820. This ensures the product meets applicable U.S. and international regulatory requirements for quality and safety. |
Users should carefully read the instructions for use before operating the device for the first time.
Try for 30 days
Order NightWatch+ now and test it for 30 days.